2m 2m 2m 2m 2m 2m 2m
HARVARD BIO (HBIO)
NASDAQ
$6.31+$0.21 (+3.44%)
Price as of Aug 03, 2026 4:10 PM EDT- $27.5MMarket Cap
- 39.88%1-Year Change
- Medical Instruments & SuppliesIndustry
HARVARD BIO (HBIO)
$6.31+$0.21 (+3.44%)
HBIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.10 | ||
Change | +$0.010 (+0.16%) | ||
Open | $6.00 | ||
High | $6.22 | ||
Low | $6.00 | ||
Previous Close | $6.09 | ||
Volume | 21,763 | ||
30-Day Average Volume | 12,308 | ||
1-Week Change | 1.67% | ||
1-Month Change | -0.81% | ||
1-Year Change | 39.88% | ||
3-Year Change | -86.88% | ||
5-Year Change | -92.27% | ||
Fundamentals | |||
Shares Outstanding | 4.5M | ||
Total Assets | $77.9M | ||
Market Cap | $27.5M | ||
Enterprise Value | $56.6M | ||
Period: QTR TTM FY | |||
Revenue | $20.8M | ||
Net Income | -$3.4M | ||
Free Cash Flow | -$1.1M | ||
EBIT | -$1.6M | ||
EBITDA | -$1.1M | ||
Net Working Capital | $23.6M | ||
EPS | -$0.77 | ||
Enterprise Value/EBITDA | -50 | ||
Enterprise Value/Revenue | 3 | ||
P/B | 3 | ||
P/E | -8 | ||
PEG | 0 | ||
Price/Free Cash Flow | -25 | ||
Price/Operating Cash Flow | -42 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 03/16/2026 | ||
Earnings & Revenue